DALLAS, Jan. 17 /PRNewswire-FirstCall/ -- BioTech Medics, Inc. (OTC Pink Sheets: BTMD), announces the hiring of BUYINS.NET. (http://www.buyins.net/ ). BUYINS.NET is initiating coverage of (OTC Pink Sheets: BTMD) after releasing the latest short sale data through January 12th, 2006. From January 2005 to early January 2006, approximately 108.4 million total aggregate shares of BTMD have traded for a total dollar value of nearly $2.14 million. The total aggregate number of shares shorted since January 2005 is approximately 8,351,702 shares. The BTMD SqueezeTrigger price of $0.02 is the volume weighted average short price that all shorts are short shares of BTMD. A short squeeze is expected to begin at $0.02, the volume weighted average price where all 8.35 million shares of BTMD have been shorted. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://buyins.net/squeezetrigger.pdf . Total Short Avg. Short Dollar Month Volume Volume Price Value January '05 4,814,122 370,687 $0.078 $28,913 February 9,649,443 743,007 $0.0575 $42,722 March 7,523,672 579,322 $0.0475 $27,517 April 3,100,115 238,708 $0.032 $7,638 May 2,938,651 226,276 $0.0255 $5,770 June 3,330,360 256,437 $0.0163 $4,179 July 1,983,493 152,728 $0.0115 $1,756 August 5,976,702 460,206 $0.0158 $7,271 September 7,655,954 589,508 $0.007 $4,126 October 2,494,677 192,090 $0.007 $1,344 November 23,584,936 1,816,040 $0.0064 $11,622 December 30,269,816 2,330,775 $0.0083 $19,345 January '06 5,141,725 395,912 $0.0071 $2,810 Total: 108,463,666 8,351,702 $0.02 $165,020 * short volume is approximated using a proprietary algorithm ** average short price is calculated using a volume weighted average short price. *** short volume is the total short trade volume and does not account for covers. BioTech Medics has acquired over $2.5 million in assets last year (with cash and treasury stock) and has a steady revenue income in the management agreement with Charles R. Crane MD & Associates in forming our first Pain Management & Wellness Center in Dallas, Texas. Additionally BTMD acquired 5 US Letters of Patent from FHJ and have started marketing the proprietary SHBAN Cleaning & Disinfecting Solution which has anti-mold, anti-fungus properties without the use of bleaches. BTMD entered into a distributorship agreement with Laser Neurotherapy Development Labs and have sold the NeuroLase Medical Laser device to clinics in the USA. We negotiated turnkey financing for the laser acquisitions through First Financial Leasing & Financing. BTMD plans on closing on more new Pain Management & Wellness Centers in 2006, as well as acquiring a permanent office building in Dallas, Texas. "We pledge to strive to add more assets and increased revenue for the company to bring more value to the stock and its more than 5,800 shareholders in 22 countries," said Keith Houser, CEO. "This in turn should provide BTMD the opportunity to become a reporting company." WWW.BUYINS.NET is a service to help bonafide shareholders of publicly traded US companies fight short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. BUYINS.NET has a proprietary database that uses list feeds to generate detailed information to combat the short selling problem. Actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades. All material herein was prepared by BUYINS.NET, based upon information believed to be reliable, but is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The company that is discussed in this opinion has not approved the statements made in this opinion. BioTech Medics purchased $995.00 worth of data used to generate this report. This PR and opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. BUYINS.NET will not advise when to sell and does not offer any opinion as to when others should sell. DATASOURCE: BioTech Medics, Inc. CONTACT: BioTech Medics, Inc., +1-972-274-5533 Web site: http://www.biotechmedics.com/ http://www.buyins.net/ http://buyins.net/squeezetrigger.pdf

Copyright